Microtubule affinity-regulating kinase 1 mRNA (MARK1 mRNA) (MARK1 mRNA)

Microtubule affinity-regulating kinase 1 (MARK1) mRNA is the transcript encoding the MARK1 protein, a serine/threonine kinase belonging to the PAR-1/MARK family (UniProt Q9P0L2). The encoded protein is a critical regulator of the cytoskeleton, functioning by phosphorylating microtubule-associated proteins (MAPs) such as Tau, MAP2, and MAP4 (Matenia & Mandelkow, 2009). This phosphorylation event triggers the dissociation of MAPs from microtubules, which is essential for maintaining the dynamic instability of the cytoskeleton required for neuronal migration, axonal transport, and cell polarity (NCBI Gene ID: 4139). Dysregulation of MARK1 mRNA expression has been implicated in several neurological disorders; for example, its overexpression is linked to the hyperphosphorylation of Tau in Alzheimer's disease, a key step in the formation of neurofibrillary tangles (Chin et al., 2000). Genetic studies have also identified MARK1 as a susceptibility gene for autism spectrum disorders, where altered expression levels may influence dendritic development and synaptic plasticity (Maussion et al., 2008). In the field of oncology, MARK1 is involved in cell motility and has been associated with the progression of certain cancers, including glioma and pancreatic cancer (PubMed). While most pharmacological research focuses on small molecule inhibitors of the MARK1 kinase domain, the mRNA itself is a target for experimental RNA-based therapies, such as small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs), aimed at reducing protein levels in pathological states (Experimental Research).

Other names

MARK1KIAA1477Microtubule affinity-regulating kinase 1MAP/microtubule affinity-regulating kinase 1

RNA interference; Antisense inhibition